Relafen 750, or advanced formulation of naproxen, presents an fascinating study from our biochemical pharmacy view. Its mechanism of action, mainly involving suppression of cyclooxygenase enzymes namely COX-1 and COX-2 – leads to a reduction in prostaglandin production. From our biochemical context, it drug's potency is strongly linked to its abi